Cargando…
COVID-19 Vaccine Could Trigger the Relapse of Secondary Hypersomnia
The coronavirus disease (COVID-19) has brought significant social and economic disruptions and devastating impacts on public health, and vaccines are being developed to combat the disease. Timely vaccination may prevent complications and morbidity but may also potentially result in unforeseen outcom...
Autores principales: | Wu, Min, Li, Shirley Xin, Xue, Pei, Zhou, Junying, Tang, Xiangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721156/ https://www.ncbi.nlm.nih.gov/pubmed/35002346 http://dx.doi.org/10.2147/NSS.S345801 |
Ejemplares similares
-
Hypersomnia
por: Dauvilliers, Yves, et al.
Publicado: (2005) -
COVID-19 and Central Nervous System Hypersomnias
por: Frange, Cristina, et al.
Publicado: (2022) -
PRIMARY HYPERSOMNIA : RESPONSE TO FLUOXETINE AND METHYLPHENIDATE
por: Andrade, Chittaranjan
Publicado: (1999) -
Symptom Severity and Treatment Satisfaction in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
por: Schneider, Logan Douglas, et al.
Publicado: (2023) -
Impairment in Functioning and Quality of Life in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
por: Stevens, Joanne, et al.
Publicado: (2023)